JDP: Emergency antihistamines

JDP Therapeutics Inc. is hoping its injectable antihistamine can become standard of care for hospitalized patients suffering acute allergic reactions. By avoiding IV diphenhydramine's multiple doses and heavy sedative effects, the company is proposing its products will improve quality of care while producing cost savings for the healthcare system.

There are two main kinds of acute allergies: those suffered at home, such as reactions to nuts, shellfish or bee stings; and drug allergies, such as to penicillin...